Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
4.220
-0.190 (-4.31%)
At close: Apr 28, 2026, 4:00 PM EDT
4.188
-0.032 (-0.77%)
After-hours: Apr 28, 2026, 6:37 PM EDT

Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $586.56 million. The enterprise value is $437.31 million.

Market Cap 586.56M
Enterprise Value 437.31M

Important Dates

The next estimated earnings date is Thursday, May 7, 2026, before market open.

Earnings Date May 7, 2026
Ex-Dividend Date n/a

Share Statistics

ACRS has 139.00 million shares outstanding. The number of shares has increased by 58.56% in one year.

Current Share Class 139.00M
Shares Outstanding 139.00M
Shares Change (YoY) +58.56%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 2.26%
Owned by Institutions (%) 43.78%
Float 95.75M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 74.95
Forward PS 118.45
PB Ratio 4.93
P/TBV Ratio 5.69
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 55.88
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.02.

Current Ratio 3.36
Quick Ratio 3.36
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -50.20% and return on invested capital (ROIC) is -35.16%.

Return on Equity (ROE) -50.20%
Return on Assets (ROA) -24.32%
Return on Invested Capital (ROIC) -35.16%
Return on Capital Employed (ROCE) -56.20%
Weighted Average Cost of Capital (WACC) 7.96%
Revenue Per Employee $107,205
Profits Per Employee -$889,356
Employee Count 73
Asset Turnover 0.04
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +214.93% in the last 52 weeks. The beta is 0.68, so ACRS's price volatility has been lower than the market average.

Beta (5Y) 0.68
52-Week Price Change +214.93%
50-Day Moving Average 3.67
200-Day Moving Average 2.73
Relative Strength Index (RSI) 55.77
Average Volume (20 Days) 1,427,824

Short Selling Information

The latest short interest is 7.07 million, so 5.09% of the outstanding shares have been sold short.

Short Interest 7.07M
Short Previous Month 7.02M
Short % of Shares Out 5.09%
Short % of Float 7.39%
Short Ratio (days to cover) 4.34

Income Statement

In the last 12 months, ACRS had revenue of $7.83 million and -$64.92 million in losses. Loss per share was -$0.53.

Revenue 7.83M
Gross Profit -52.10M
Operating Income -74.08M
Pretax Income -64.92M
Net Income -64.92M
EBITDA -74.04M
EBIT -74.08M
Loss Per Share -$0.53
Full Income Statement

Balance Sheet

The company has $90.75 million in cash and $2.12 million in debt, giving a net cash position of $149.25 million or $1.07 per share.

Cash & Cash Equivalents 90.75M
Total Debt 2.12M
Net Cash 149.25M
Net Cash Per Share $1.07
Equity (Book Value) 103.08M
Book Value Per Share 0.86
Working Capital 67.67M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$47.11 million and capital expenditures -$111,000, giving a free cash flow of -$47.22 million.

Operating Cash Flow -47.11M
Capital Expenditures -111,000
Depreciation & Amortization 40,000
Net Borrowing n/a
Free Cash Flow -47.22M
FCF Per Share -$0.34
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -946.52%
Pretax Margin -829.58%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -58.56%
Shareholder Yield -58.56%
Earnings Yield -11.07%
FCF Yield -8.05%

Analyst Forecast

The average price target for ACRS is $9.80, which is 132.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.80
Price Target Difference 132.23%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 62.40%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

ACRS has an Altman Z-Score of -7.22 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -7.22
Piotroski F-Score 1